Published July 3, 2026 | Version v2

The Tissue Governance Failure Framework (TGFF): Multi-Scale Command Collapse and the Emergence of Malignant Autonomy

Description

Version 2.0 of the Tissue Governance Failure Framework. Expands the core proposition of v1.0 into a complete architecture of governance collapse through six new principles:

1. Multi-Scale Governance Collapse Model (MGCM): four-tier command hierarchy with operational biomarkers enabling governance collapse scoring via the Governance Collapse Index (GCI).

2. Local Emergency Sovereignty (LES): when central command fails, local tissues assume emergency authority — the governance root of Tactical Tolerance.

3. Brain Ceasefire Principle (BCP): the neuroimmune axis may act as a systemic survival arbitration layer that terminates total war when elimination cost threatens organismal survival.

4. Hierarchical Surrender Cascade (HSC): governance failure propagates upward through the command hierarchy.

5. Delayed Reawakening Principle (DRP): terminated wars resume when threat thresholds are breached.

6. Hematologic Null Model (HNM): hematologic malignancies lack localized tissue-governance architecture and therefore bypass containment-centered governance dynamics — explaining their unique curability.

New in v2.0: Governance Collapse Index (GCI) with weighted extension (wGCI), Bidirectional Governance Logic, operational biomarker matrix, four TikZ figures, 14 testable predictions, cross-framework integration with SPDS v5.0 and QCH v2.2, NHH hook for governance capture.

Together with SPDS v5.0 (Ignition Canon) and QCH v2.2 (Containment Canon), TGFF v2.0 completes the three-pillar core of the Abuamra Framework.

Files

Abuamra_MFY_TGFF_v2_0_2026_tex (1).pdf

Files (204.1 kB)

Name Size
md5:02cefd66231f6137507a378b21507a8c
203.7 kB Preview Download
md5:00ec33bff7c832a8d26d70932ad262d9
462 Bytes Download

Additional details

Additional titles

Alternative title
The Tissue Governance Failure Framework: A Unified Systems-Level Theory of Carcinogenesis — From Repair Exhaustion to Malignant Evolution

Related works

Is supplement to
Preprint: 10.5281/zenodo.20180050 (DOI)
Preprint: 10.5281/zenodo.20623694 (DOI)

References

  • Abuamra, M.F.Y. (2026). Governance Failure Framework for Malignant Transition: The SPDS/Dual-Hit Model and the Absent Sentinel Hypothesis (Version 4.0). Zenodo. https://doi.org/10.5281/zenodo.20559357 Abuamra, M.F.Y. (2026). The Quarantine Capsule Hypothesis: Reinterpreting Solid Tumors as Maladaptive Host Containment Structures (Standalone v1.4). Zenodo. https://doi.org/10.5281/zenodo.20559953 Abuamra, M.F.Y. (2026). Quarantine Capsule Extensions: Leukemia as Containment Failure, the Sentinel Node as Coordinator, and Lymphoma as Multi-Nodal Containment (v1.2 Final). Zenodo. Apte, M.V., Wilson, J.S., Lugea, A., & Pandol, S.J. (2015). A starring role for stellate cells in the pancreatic cancer microenvironment. Gastroenterology, 144(6), 1210-1219. Bi, J., Zhang, Q., Liang, D., Xiong, L., Wei, M., Sun, R., & Tian, Z. (2023). T-cell exhaustion and cancer immunotherapy. Signal Transduction and Targeted Therapy, 8(1), 402. Botelho, M.C., Vale, N., & Brindley, P.J. (2013). Schistosoma haematobium and bladder cancer: what lies beneath? Virulence, 4(8), 736-738. Coussens, L.M., & Werb, Z. (2002). Inflammation and cancer. Nature, 420(6917), 860-867. Dvorak, H.F. (1986). Tumors: wounds that do not heal. New England Journal of Medicine, 315(26), 1650-1659. El-Serag, H.B. (2011). Hepatocellular carcinoma. New England Journal of Medicine, 365(12), 1118-1127. Green, D.R. (2012). Means to an End: Apoptosis and Other Cell Death Mechanisms. Cold Spring Harbor Laboratory Press. Ichim, G., et al. (2015). Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. Molecular Cell, 57(5), 860-872. Itzkowitz, S.H., & Yio, X. (2004). Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease. American Journal of Physiology-Gastrointestinal and Liver Physiology, 287(1), G7-G17. Lambeth, J.D. (2004). NOX enzymes and the biology of reactive oxygen. Nature Reviews Immunology, 4(3), 181-189. Lu, C., He, J., & Liu, X. (2018). Reactive oxygen species in cancer theranostics. Theranostics, 8(11), 2912-2919. Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008). Cancer-related inflammation. Nature, 454(7203), 436-444. Schafer, M., & Werner, S. (2008). Cancer as an overhealing wound: an old hypothesis revisited. Nature Reviews Molecular Cell Biology, 9(8), 628-638. Shaheen, N.J., & Falk, G.W. (2018). The rising tide of esophageal adenocarcinoma. Gastroenterology, 154(8), 2154-2156. Stratton, M.R., Campbell, P.J., & Futreal, P.A. (2009). The cancer genome. Nature, 458(7239), 719-724. Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A., & Kinzler, K.W. (2013). Cancer genome landscapes. Science, 339(6127), 1546-1558. Wiseman, H., & Halliwell, B. (1996). Damage to DNA by reactive oxygen and nitrogen species. Biochemical Journal, 313(1), 17-29.